Terminated PHASE2 INTERVENTIONAL NCT00383487

A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate Cancer

Sponsor: Novacea

Conditions Prostate Cancer Prostatic Neoplasms

Interventions Calcitriol Naproxen-n-butyl nitrate

Updated 5 times since 2017 Last updated: Jan 25, 2013 Started: Mar 31, 2005 Primary completion: Jul 31, 2007 Completion: Jul 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Extreme toxicity

Other terminated trials from Novacea

Prostate Cancer · Phase PHASE3 · Nov 2007

More terminations from Novacea

Other Prostate Cancer trials with similar outcome

Browse all Prostate Cancer trials

This PHASE2 trial investigates Prostate Cancer and Prostatic Neoplasms and is currently terminated or withdrawn. Novacea leads this study, which shows 5 recorded versions since 2005 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE2
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE2
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE2

First recorded

Mar 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Novacea
Stanford University

Data source: Stanford University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Stanford, United States